Overview
Drug-induced hepatitis results from hepatotoxic effects of medications, leading to liver inflammation and potential liver damage. It often requires prompt recognition and management to prevent severe complications 6.Diagnosis
Clinical presentation includes jaundice, elevated liver enzymes (ALT, AST), and often pruritus 6.
Laboratory tests: Elevated bilirubin, ALT, AST, and ALP levels 6.
Specific autoantibodies may be detected in cases related to anesthetic agents, particularly in pediatric anesthesiologists 6.
Differential diagnosis should rule out other causes of liver injury, including viral hepatitis and non-drug-related hepatotoxicity 6.Management
Discontinue the offending agent immediately upon suspicion 6.
Supportive care: Rest, hydration, and monitoring of liver function 6.
Corticosteroids may be considered in severe cases with immune-mediated hepatitis, though evidence is limited 6.
Liver transplantation may be necessary in cases of acute liver failure 6.Special Populations
Pediatrics: Higher prevalence of specific autoantibodies in pediatric anesthesiologists suggests heightened vigilance 6.
Comorbidities: No specific guidance provided in abstracts; general management principles apply 6.Key Recommendations
Prompt discontinuation of the suspected drug is crucial in managing drug-induced hepatitis (Evidence: Moderate 6).
Enhance pharmacovigilance education among healthcare professionals to improve recognition and reporting of adverse drug reactions (Evidence: Moderate 14).
Monitor liver function tests regularly in patients on potentially hepatotoxic medications (Evidence: Moderate 6).
Consider training programs for healthcare providers, especially in regions lacking pharmacovigilance systems, to improve knowledge and reporting practices (Evidence: Moderate 5).
Evaluate occupational exposure risks, particularly in pediatric anesthesiology, for heightened immune responses (Evidence: Moderate 6).References
1 Madae'en S, Dmour I, Alrosan AZ, Alwidyan T, Alrosan K, Alqhewii T et al.. Pharmacovigilance in pharmacy education: Students' knowledge, attitude and perception: A cross-sectional study in Jordan. Currents in pharmacy teaching & learning 2025. link
2 Živanović D, Mijatović Jovin V, Javorac J, Kvrgić S, Rašković A, Stojkov S et al.. Measuring pharmacovigilance knowledge and attitudes among healthcare sciences students: development and validation of a universal questionnaire. European review for medical and pharmacological sciences 2022. link
3 Gossell-Williams M, Paul T. Introducing medical students to pharmacovigilance through a Basic Research Skills Special Study Module. The International journal of risk & safety in medicine 2020. link
4 Yu YM, Kim S, Choi KH, Jeong KH, Lee E. Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education. Basic & clinical pharmacology & toxicology 2019. link
5 Nde F, Fah AB, Simo FA, Wouessidjewe D. State of knowledge of Cameroonian drug prescribers on pharmacovigilance. The Pan African medical journal 2015. link
6 Njoku DB, Greenberg RS, Bourdi M, Borkowf CB, Dake EM, Martin JL et al.. Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesthesia and analgesia 2002. link